Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754598 · ClinicalTrials.gov registry record · NA
Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography
A NA study of Breast Cancer, sponsored by Hologic.
- Completed
- Registry status
- NA
- Development phase
- 1,183
- Enrollment target
- 5
- Study locations
NCT00754598: Completed NA study of Breast Cancer, sponsored by Hologic.
NCT00754598 is a NA study of Breast Cancer that has completed, run by Hologic. The registered enrollment target is 1,183 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (58% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00754598, a NA study of Breast Cancer, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,183 participants
- Enrollment target
- 5
- Study locations
Study Summary
This was a multi-center, prospective clinical trial in which the subject was her own control. Approximately 950-1400 female subjects were enrolled at five (5) sites in the United States. Subjects were from either a Screening population or a biopsy population and were imaged first on a conventional 2D full filed digital mammography system then on a 3D tomosynthesis system. The resulting images from the this portion of the study were then randomized into a reader study. The purpose of this clinical study was to compare the 3-D tomosynthesis system used in conjunction with a conventional 2-D digital imaging system (2-D plus 3-D images) to the conventional 2-D digital imaging system (2-D images), and to determine whether the 2-D plus 3-D images compared to the 2-D images alone would: 1. Reduce the recall rate And/or 2. Improve ROC area due to improved breast cancer detection and/or improved lesion classification.
Conditions Studied
Interventions
- DEVICE Tomosynthesis digital mammography imaging system
Study Locations (5)
Connecticut
- Yale New Haven Hospital - New Haven
Iowa
- University of Iowa Medical Center - Iowa City
Massachusetts
- Massachusetts General Hospital - Boston
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Pennsylvania
- Magee Women's Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,183 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-07 |
| Phase | NA |
What the finished NCT00754598 record still lists
NCT00754598 is an interventional study that assigns participants to a tested intervention. Its 1,183 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Tomosynthesis digital mammography imaging system is the first listed.
NCT00754598 lists 5 locations in 5 states (Connecticut, Iowa, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00754598 about?
NCT00754598 is a clinical study titled "Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography". This was a multi-center, prospective clinical trial in which the subject was her own control. Approximately 950-1400 female subjects were enrolled at five (5) sites in the United States. Subjects were from either a Screening population or a biopsy population and were imaged first on a conventional 2...
What is the current status of trial NCT00754598?
This trial is currently completed. It is a NA study. The enrollment target is 1,183 participants. The study started on 2006-07. Estimated completion is 2007-07.
What conditions does trial NCT00754598 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00754598?
The interventions under investigation include: Tomosynthesis digital mammography imaging system (DEVICE).
Who is sponsoring clinical trial NCT00754598?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00754598 being conducted?
This trial has 5 study locations across Connecticut, Iowa, Massachusetts, New Hampshire, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00754598's enrollment target sits among peer trials
1,183 107th of 1224 higher than 1,118 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia